Cat.#: ACPP-1391
| Despition | Apolipoprotein-D Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95% (SDS-PAGE) |
| Form | Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1172 | Native Human Prostate Specific Antigen (Functional) - Low endotoxin (AC1172) | 1 mg | inquiry |
| ACPP-1373 | Human Interleukin 6 (Active) Protein (AC1373) | 10 µg | inquiry |
| ACPP-1420 | MOG (AC1420) | 5 mg | inquiry |
| ACPP-1309 | CCR5 Blocking Peptide (AC1309) | 250 µg | inquiry |
| ACPP-1072 | Synaptophysin Blocking Peptide (AC1072) | 250 µg | inquiry |
| ACPP-1463 | Human BCL2L11 Protein (AC1463) | 2 µg | inquiry |
| ACPP-1198 | PDE6 Alpha Blocking Peptide (AC1198) | 250 µg | inquiry |
| ACPP-1329 | PDE6 Beta Blocking Peptide (AC1329) | 250 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1078 | Glutamate Receptor 1 Blocking Peptide (AC1078) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.